Tradestie Institutional Equity Comparison Engine
AKAN vs NEXR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NEXR Overall Edge
NEXR Captures Institutional Edge (2โ1 Pillars ยท 1โ7 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NEXR (NEXR) driven by superior Momentum & Technical, Options & Structure while AKAN counters with relative strength in Growth & Margin. Fundamentally, AKAN trades at N/M Forward P/E with -1254.5% operating margin (+21.9% YoY revenue) versus NEXR at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, AKAN sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against NEXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
AKAN N/M vs NEXR N/M Fwd P/E
Growth & Margin Winner
AKAN
Op Margin -1254.5% vs N/A ยท YoY +21.9% vs N/A
Momentum & Technical Winner
NEXR
1Y +55.0% vs -39.2% ยท 52W Pos 2% vs 23%
Options & Structure Winner
NEXR
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
AKAN
NASDAQ
Akanda Corp. Common Shares
Medicinal Chemicals & Botanical Products
$2.00
+47.05% 1D
Market Cap
$2.2M
1M Return
+66.66%
1Y Return
+55.03%
Forward P/E
N/M
Unified AI Score
43.8 / 100
HOLD
Tech 20.0
Fund 60.0
Flow 50.0
Mom 70.0
NEXR
US Equity
NEXR
Institutional Equity
$1.38
-7.38% 1D
Market Cap
N/A
1M Return
+67.27%
1Y Return
-39.21%
Forward P/E
N/M
Unified AI Score
31.0 / 100
SELL
Tech 50.0
Fund 27.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AKAN +55.03%
NEXR -39.21%
Spread: +225.77 pp (AKAN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AKAN TTM Op. Margin: -1254.5%
NEXR TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AKAN vs NEXR. Trailing 12-month operating profitability (AKAN -1254.5% vs NEXR N/A) and valuation multiples (AKAN N/M vs NEXR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AKAN | NEXR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.2M | N/A | Larger Scale | AKAN |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +21.9% | N/A | Higher Growth | AKAN |
| Operating Margin (TTM) Profitability | -1254.5% | N/A | Higher Margin | AKAN |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | AKAN |
| Return on Equity (ROE) Capital Efficiency | -60.9% | N/A | Higher ROE | AKAN |
| 52-Week Range Position Momentum | 2% ($0โ$79) | 23% ($0โ$5) | Stronger Trend | NEXR |
| Beta / 30D Volatility Risk Regime | 5.43ฮฒ ยท 428% Vol | 8.42ฮฒ ยท 2730% Vol | Lower Realized Risk | AKAN |
| Unified Institutional Score Composite Signal | 43.8 / 100 (HOLD) | 31.0 / 100 (SELL) | Higher Composite | AKAN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AKAN vs NEXR Buy Guide
AKAN
BREAKDOWN
137d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NEXR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AKAN nor NEXR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.